Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
about
Protein lysine acetylation by p300/CBPStructure of the p300 catalytic core and implications for chromatin targeting and HAT regulationOncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesisB56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradationHistone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 associationTranscriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancersStructure of a biologically active estrogen receptor-coactivator complex on DNA.The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases.p300/CBP and cancer.The role of TGF-beta in epithelial malignancy and its relevance to the pathogenesis of oral cancer (part II).A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instabilityp300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma.Molecular mechanisms of head and neck cancer.The role of p300 in the tumor progression of oral squamous cell carcinoma.Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.Expression of histone acetylases p300 and PCAF in pediatric astrocytomas.A rearranged EP300 gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity.Promoter context determines the role of proteasome in ligand-dependent occupancy of retinoic acid responsive elements.Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes.Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition.Notch1 oncoprotein antagonizes TGF-beta/Smad-mediated cell growth suppression via sequestration of coactivator p300.Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.Regulation of the human involucrin gene promoter by co-activator proteins.Human histone H3K79 methyltransferase DOT1L protein [corrected] binds actively transcribing RNA polymerase II to regulate gene expression.Concomitant increase of histone acetyltransferase activity and degradation of p300 during retinoic acid-induced differentiation of F9 cells.ATAC is a double histone acetyltransferase complex that stimulates nucleosome sliding.Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells.Sequence-selective DNA recognition and enhanced cellular up-take by peptide-steroid conjugates.
P2860
Q27021749-FAE9C949-82CB-42CF-B727-022A9E199ECFQ27685367-047CCDA5-54B0-4BCE-80BA-5DA640C1F9E0Q28296317-D6488145-3A7C-47FA-89B1-70AC17A3BCF2Q33695448-4ECD590C-844A-4FE9-BE94-1098FAB196A4Q33770877-2A6D021C-901F-4418-91FB-4D18D63C5A05Q34013630-082F3837-3FBB-4192-BD70-08F993E76709Q34619360-F5C0B67D-5BA0-4EF5-B013-15DABE7B572AQ35205425-261164CF-D689-4748-AE73-0349C3026A7BQ35666251-D255698C-74DB-42DD-B0F1-6F88F6A7A02BQ35779695-BCB99BD5-24E8-40A4-9641-72677CD454C8Q35969342-49FF8D25-1CF3-47DA-B015-36901499C9BCQ36017683-CF2D773D-10B9-44BE-A3D8-D3885D5655D9Q36172205-619093CA-AD00-4D7B-9698-F768BE52A85CQ37159537-2B519989-486E-4159-AE2A-2F97B4CA72E6Q38963086-992946F0-7C61-4566-80F6-FD357B05D1DDQ39018415-3C346CB5-2A9A-4232-BD09-6BBBB9D5FA0FQ39194917-DC0B0F21-B16E-4E44-9A3B-50F7E782764CQ39608218-91EAE917-5246-42B0-B655-923FBE667D2BQ39643895-6ECE0A02-EC2F-4386-93A5-E9A1A422F9A3Q39699914-3A7D6EFB-55F1-4795-8779-2CDF6D1769F0Q40290515-C955D088-1A3D-4E80-8F25-564AB85BB582Q40420353-60BD2D20-CF8C-4CE7-8FE5-DB51CB5D8CAFQ40443907-67EDB316-55CD-4A40-ACA0-3E048176F06BQ40577860-B1BD3480-04EF-4D61-8826-2A5C4D6C2F81Q41461116-BFA0A673-2D66-4636-A419-56CAE262C8C9Q44530893-376D88CB-B27B-4AE8-8B86-AA36007EF7D7Q46713379-3E3AB1C0-0082-4C9B-900F-AB81EB4B5E00Q46772713-365843B3-3312-4FF3-84FF-13280871BBE4Q49105554-B1224F57-07CF-42D7-B7B8-45741AC3B705
P2860
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
@ast
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
@en
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
@nl
type
label
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
@ast
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
@en
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
@nl
prefLabel
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
@ast
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
@en
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
@nl
P2093
P2860
P356
P1476
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
@en
P2093
Masa-Aki Ikeda
Masahiro Kawabata
Tamaki Suganuma
Tomoko Ohshima
P2860
P304
13073-13078
P356
10.1073/PNAS.192586699
P407
P577
2002-09-17T00:00:00Z